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Abstract: In this work, a new methodology is reported
for developing hydroxyapatite (HA) scaffolds using an
organic sacrifice template. The novelty of work consists of
possibility of obtaining porous and highly interconnected
scaffolds mimicking the sacrificial component. Our pur-
pose consisted of evaluating the physicochemical proper-
ties of the HA scaffolds by means of Fourier transform
infra-red spectroscopy, X-ray diffraction analysis, and
scanning electron microscopy (SEM) attached with an X-
ray detector. The HA scaffolds obtained possess a poros-
ity of !70%, and macropores diameter in the range of
50–600 lm. In contrast, results regarding the microcom-
puted tomography analysis have demonstrated both high
pore uniformity and interconnectivity across the scaffolds.
The compressive strength of the HA scaffolds was found
to be 30.2 6 6.0 MPa. Bioactivity of the HA scaffolds was
assessed by immersion into a simulated body fluid solu-
tion, in vitro. SEM observations have showed a deposition
of apatite on the surface of the HA scaffolds, with a ‘‘cau-
liflower-like’’ morphology after 1 day, and tend to be
more pronounced with the immersion time. The changes
in calcium and phosphorus concentration were monitored
by inductively-coupled plasma optical emission spectrom-
etry. Cytotoxicity of the HA scaffolds was preliminarily
investigated by carrying direct observation of mouse
fibroblasts cells (L929 cell-line) death in the inverted
microscope, and then cell viability was determined by
means of carrying out a MTS assay. Complementarily, a
luminescent cell viability assay based on the quantifica-
tion of adenosine triphosphate was performed using rat
bone marrow stromal cells (RBMSCs). A LIVE/DEAD
assay and SEM analysis allowed the visualization of the
RBMSCs adhesion and proliferation on the surface of the
HA scaffolds. According to the results obtained from 3D
architecture, mechanical properties, biocompatibility, and
adhesion tests, it is suggested that HA scaffolds has
potential to find applications in bone tissue engineering
scaffolding. ! 2008 Wiley Periodicals, Inc. J Biomed
Mater Res 91A: 175–186, 2009
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INTRODUCTION
Bone lesions above a critical-sized segmental
defect remain a huge challenge to reconstructive sur-
gery and regenerative medicine. This is mainly due
to the fact that bone has a limited ability to heal.1,2
In many clinical situations there is the need for a
surgical intervention and the use of autografts,3,4 al-
lografts, or xenografts4,5 transplantation. Still, the
preferred clinical strategy is the autologous trans-
plantation, because it avoids the problem of immune
rejection6 and the consequent administration of
drugs for immunosupression of the host.7 Bone auto-
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grafts consists of bone portions either cancellous or
cortical,4 harvested from other skeletal locations,
which are then transferred into the defect area that
is aimed to repair.8 Although, the limited bone graft
volume available, consequent donor site morbidity5,9
and postoperative pain10 are seen as the major con-
straint in using autografts. Therefore, we can say
that the currently available treatment possibilities
are far from being a truly ideal solution. To circum-
vent these limitations great efforts are focused on
developing implantable materials either synthetic or
natural-based to be used as implants.11–13 For instan-
ces, synthetic materials based on hydroxyapatite
(HA), Ca10(PO4)6(OH)2, have demonstrated a great
potential for being used as bone substitutes13–15 or
fracture repair devices.16 The great interest in using
HA or other ceramic materials arises from the possi-
bility to improve the clinical outcome because of
their osteoconductive behavior.14,17 However, these
biomaterials alone are not always as effective as
bone autografts, because they lack the osteogenic
and osteoinductive properties.18,19
More recently, it has been reported that by apply-
ing the tissue engineering (TE) principles,10 that is
by seeding bone marrow stem cells into scaffolds,
the so-called constructs20 or prostheses,21 it was pos-
sible to recreate an regenerative environment at the
defect area, which resulted in a more favorable heal-
ing. Despite the important advances, a wide range of
problems related with the tissue-engineering
approaches remains unsolved. For example, many
bone tissue engineering constructs developed
showed that bone formation in vitro, only occurred
at the surface.22 Therefore, it seems that much has to
be done and improvements of the cell culture techni-
ques23 and appropriate scaffolds architecture are
needed for developing successful constructs that can
be used in the clinical practice. Therefore, there is
the need for continuously improving the develop-
ment of processing routes towards the fabrication of
biocompatible with adequate 3D porous structures
and mechanical properties.
In this work, we report a methodology for devel-
oping HA scaffolds with a controllable architecture
to find applications in tissue engineering of bone
scaffolding. The physicochemical characterization of
the macroporous HA scaffolds was performed by
using Fourier transform infra-red (FTIR) spectros-
copy, X-ray diffraction (XRD) analysis, and scanning
electron microscopy attached with an X-ray detector
(SEM/EDS). The microstructure of the HA scaffolds
was examined using microcomputed tomography
(l-CT) analysis. The mechanical properties of the HA
scaffolds were assessed under compression testing.
The bioactive behavior of the HA scaffolds was
assessed by immersion into a simulated body fluid
(SBF) solution. The changes in calcium and phos-
phate concentration in the SBF solution were moni-
tored by inductively-coupled plasma optical emis-
sion (ICP-OES) spectrometry.
Cytotoxicity of the HA scaffolds leachables was
evaluated by carrying out a cellular viability assay
(MTS test) on mouse lung fibroblasts cells, which
were previously in contact with the different HA
extract fluids. Rat bone marrow stromal cells adhe-
sion and morphology were also analyzed by SEM
and under a 3D fluorescence microscope, whereas
the cell viability and proliferation were assessed by
carrying out the Luminescent and LIVE/DEAD cell
viability assays.
MATERIALS AND METHODS
Preparation of HA scaffolds
Calcium hydroxide (Riedel-de Hae¨n, Germany) and
ortho-phosphoric acid 85% (Panreac, Spain) solution were
used to prepare separately, two precursors (Ca and P) sol-
utions. HA powders were obtained by adding in a con-
trolled manner, appropriate amounts (Ca/P molar ratio of
1.67 was always used) of these solutions, using a peristaltic
pump (Gilson Miniplus 3, France) at a speed rate 17 mL
min21. The precipitation of the HA particles occurred by
adjusting the pH of the media to 11 with a 33% ammo-
nium hydroxide (Riedel-de Hae¨n, Germany) solution.
Then, precipitate was filtered under vacuum and the
excess of water removed by drying the filtrate at 608C for
24 h. After milling the HA pellets until obtain a fine pow-
der, the HA scaffolds were fabricated. The procedure for
obtaining the HA scaffolds is summarized in Figure 1.
Firstly, a HA slurry was prepared by dispersing HA pow-
ders in methanol for 48 h (step 1). Then, polyurethane
(PU, Eurospuma SA, Portugal) cylindrical sponges (10 3
8 mm2) featuring fully interconnected pores were dipped
into the slurry until total impregnation. To prevent the for-
mation of an external skin-like layer, the impregnated PU
sponges were transferred to a centrifuge and the excess of
slurry was removed by centrifuging at 60 rpm for 1 min
(step 2), followed by drying at 378C, for 24 h (step 3) to
avoid the formation of cracks. Finally, the impregnated
sponges were placed inside the furnace and the PU matri-
ces burned at 9008C for 24 h, followed by sintering the HA
scaffolds at 13008C for 3 h (step 4). The HA scaffolds were
allowed to naturally cool inside the furnace (step 5) and
finally sterilized by ethylene oxide gas. Figure 2 shows the
typical HA scaffolds obtained, where replica of the PU
sponge pores can be observed.
Characterization of the HA scaffolds
Fourier-transform infra-red spectroscopy
Potassium bromide (KBr, Riedel-de Hae¨n, Germany)
was used to prepare transparent discs [1:10 of sample/KBr
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(wt/wt)] for Fourier transform infra-red (FTIR) analysis. A
Perkin-Elmer 1600 series spectrophotometer (Perkin-Elmer,
UK) was used to record the spectra that were collected
with a minimum of 32 scans and resolution of 2 cm21. The
chemical changes of HA after sintering was examined over
a region of 4400–450 cm21.
Thermogravimetric analyses
Thermal stability and composition of the PU sponges,
PU sponge impregnated with HA before burning, and HA
scaffolds sintered at 13008C was assessed by thermogravi-
metric (TGA) analysis. A TA-Q500 analyser (TA Instru-
ments, USA) was used. The data were obtained using a
ramp rate of 58C min21.
X-ray diffraction measurements
Crystallinity and phase content of HA powder, sintered
HA and HA scaffolds were investigated with X-ray diffrac-
tion (XRD) analysis, using an X-ray diffractometer (Philips
PW 1710, The Netherlands). XRD patterns were examined
in the region of 2–658 with a step size 0.028 for 2u and
scan speed of 0.68 per min.
Scanning electron microscopy
A scanning electron microscope attached with an energy
dispersive electron probe X-ray analyzer (SEM-EDS, Leica
Cambridge S-360, UK) was used to analyze both micro-
structure of HA scaffolds before and after immersion into
a simulated body fluid (SBF) solution, and PU sponges.
All specimens were coated with gold using a Polaron SC
502 (Fisons Instruments, UK) coater, prior to observation.
Micro-computed tomography
The 3D structural and architectural information of the
HA scaffolds was assessed quantitatively and qualitatively,
by means of microcomputed tomography (l-CT) analysis
and using a Scanco 20 equipment (Scanco Medicals, Swit-
zerland). A series of about 900 2D slices with a scanning
resolution of 11 lm were obtained by irradiating the speci-
men with penetrative X-rays of 50 keV. Mimics1 from
Materialise (Belgium) was used as image processing soft-
ware. The porosity along the HA scaffolds was also eval-
Figure 2. Macroscopic appearance of the HA scaffolds after
sintering at 13008C. [Color figure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
Figure 1. Schematic representation of the production route of the HA scaffolds.
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uated by 2D histomorphometric analysis using a threshold
300 (Th 300).
Mechanical testing
Compression tests (dry state) were performed using a
Universal Testing Machine (Instron 4505) containing a load
cell of 50 kN. Experiments were conducted using a mini-
mum number of 10 scaffolds.
Bioactivity test
HA scaffolds were immersed in a simulated body fluid
(SBF) solution at (37 6 1)8C to assess the bioactivity in
vitro.24 After each immersion time (1, 3, 7, and 15 days),
the scaffolds were immediately rinsed with distilled water,
dried at room temperature for 24 h and then dried in the
oven at 608C until constant weight. The concentration of
the Ca and P ions in the SBF solution was also measured
by inductively-coupled plasma optical emission (ICP-OES,
JY 70 plus, JobinYvon, France) spectrometry. Triplicate
samples were analyzed for each immersion time and aver-
aged results calculated.
In vitro cell culture studies
Cytotoxicity screening
The MTS viability test was performed to investigate the
cytotoxicity of the HA scaffolds leachables. A cell line of
mouse lung fibroblasts (L929 cells) purchased from Euro-
pean Collection of Cell Cultures (ECACC, UK). This type
of cells has been used in cytotoxicity assays to preliminar-
ily test biocompatibility of potential biomaterials.25 L929
cells were cultured in an DMEM (Dulbecco’s-Modified
Eagle’s Medium, Sigma, Germany) medium supplemented
with 10% fetal bovine serum (FBS, Gibco, UK), 1% antibi-
otic-antimycotic (Gibco, UK) solution containing 10,000
units mL21 penicillin G sodium, 10,000 lg mL21 strepto-
mycin sulphate and 25 lg mL21 amphotericin B as Fungi-
zone1 in 0.85% saline. The L929 cells were incubated in an
atmosphere containing 5% of CO2 at 378C, and the me-
dium changed every 2 days.
The extracts fluid were prepared as previously reported
by Gomes et al.25 Succinctly, extracts fluids were obtained
by introducing the HA scaffolds in a 50 mL conical tube
with flip-top cap (BD FalconTM, USA) and complete
DMEM culture medium was added. For all tests a ratio of
outer surface of HA scaffolds to DMEM medium equal to
30 cm2 mL21 was used. Then, the tubes were transferred
to a thermostatic bath at 378C and 60 rpm for the period
of 3 days. Different concentrations of HA scaffolds extracts
(25, 50, 75, and 100%) were prepared. A latex rubber
extract was used as positive control.
After reaching confluence, L929 cells were trypsinized
(0.25% trypsin/EDTA solution, Sigma Chemical, USA)
from a culture flask, and a diluted cell suspension was
prepared to achieve a cellular concentration of 8 3 104
cells mL21. Afterwards, 1.6 3 104 cells were seeded in
each well of a 96-well plate (five replicates per sample).
Cells were incubated for 48 h in a 5% CO2 incubator at
378C, until achieving 80–90% of confluence. Afterwards,
the culture medium in each well was replaced with the
extraction fluids and incubated for 72 h. Then, an MTS
assay was performed using 3-(4, 5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)
(MTS, Promega, USA), whereas cellular morphology was
assessed by optical microscope (Zeiss-Axiovert 40, Ger-
many). The cell viability (%) was calculated and compared
with the tissue culture polystyrene (TCPS). All experi-
ments were performed in triplicate.
Cell viability and adhesion studies
Rat bone marrow stromal cells (RBMSCs) were obtained
from femora of 7 week-old male Fischer 344/N rats (SLC,
Japan). The animals were sacrificed following the protocol
approved by the Ethics Committee at the Tissue Engineer-
ing Research Center (Amagasaki, Japan). Then, the femoras
were collected under aseptic conditions, and the soft tissue
were eliminated. The epiphyseal regions were removed
and the marrow flushed out with freshly prepared com-
plete Eagle’s minimum essential medium (MEM, Nacalai
Tesque, Japan) with 15% FBS (JRH Biosciences, USA) and
1% antibiotic-antimycotic (Nacalai Tesque, Japan) solution,
into a 15 mL Falcon. The RBMSCs were expanded in
T75 cm2 (BD Biosciences Discovery Labware, Bedford, USA)
culture flasks in the presence of complete culture medium
and expanded under standard culturing conditions. The
culture medium was changed each 2 or 3 days. After cells
reach confluency, 1 mL of 0.05% tripsin-0.53 mM EDTA
(Invitrogen, USA) solution was added to detach the cells
from the substrate. Then, complete culture medium was
added and RBMSCs (passage 1, P1) were centrifuged at
900 rpm for 5 min. The cells re-suspended with 10 mL of
complete culture medium, and cells counted using an auto-
mated counter (Cell Counter Sysmex F-520, Japan). Viability
of RBMSCs was also analyzed with a NucleoCounter (Che-
mometec, Denmark), prior seeding.26 After that, RBMSCs
were seeded onto the HA scaffolds at a cellular density of
5 3 102 cells per scaffold, 1 3 103 cells per scaffold, 5 3 103
cells per scaffold and 1 3 104 cells per scaffold and cultured
in MEM medium for 24 h, 3 and 7 days under static condi-
tions. After each time period, the ATP content which signals
the presence of metabolically active cells was measured by
means of performing a CellTiter-Glo1 luminescent cell via-
bility assay (Promega Corporation, USA). The luminescence
was measured using opaque-walled multi-well plate in a
microplate reader (Wallac ARVOsx 1420, Perkin-Elmer Life
and Analytical Sciences, USA). This assay is based on a lu-
minescence signal that is proportional to the amount of
ATP, which by its turn is directly proportional to the num-
ber of viable cells.
Moreover, cell adhesion and proliferation were investi-
gated using a LIVE/DEAD viability assay kit (Molecular
Probes). RBMSCs were incubated with two probes, calcein-
AM (green color) and ethidium homodimer-1 (EtdD-1,
bright red color), for intracellular esterase activity and
plasma membrane integrity, respectively.27 Then, speci-
mens were observed under a 3D fluorescence microscope
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(Olympus SZX12 stereomicroscope, OLYMPUS, Japan) and
SEM. All experiments were carried out three times using a
minimum of three samples per experimental condition.
RESULTS AND DISCUSSION
There is a huge clinical demand for novel syn-
thetic tissue engineered scaffolds. Porosity, pore size
and interconnectivity of the biomaterial scaffolds are
known to play a critical role in bone formation.28
Therefore, among the key requirements that should
be idealized, scaffolds architecture is one of the most
important features. However, the balanced porosity/
mechanical performance of the scaffolds is an issue
that must not be forgotten, and thus should also be
explored. To address this issue the present work
describes a methodology for the preparation of HA
scaffolds to find applications on bone tissue engi-
neering. These scaffolds were successfully obtained
by impregnating a PU sponge with HA particles, fol-
lowed by burning the sacrifice polymeric template
and sintering the final HA porous structure (Fig. 1).
It is noteworthy that centrifugation (step 2) is a cru-
cial for optimizing the 3D architecture of the scaf-
folds. It removes the excessive impregnation of HA
slurry and this method allows obtaining a uniform
porosity across the scaffold and macro- and open-
pore structure.
The macroscopic appearance of the typical HA
scaffold is shown in Figure 2. It can be observed that
the HA scaffolds retained the typical shape of the
original PU sponge and possess a trabeculae-like
architecture.
FTIR analysis was performed to assess the chemi-
cal changes on the HA structures during processing.
Figure 3 shows the FTIR spectra of HA before and
after sintering. The results confirmed previous
ones29 that demonstrated, in both cases the existence
of characteristic bands of HA, namely at 598 and
559 cm21 (*), and at 1020 cm21 (*) attributed to
PO4
32 (m4) and PO4
32 (m3) groups, respectively
[Fig. 3(a–c)]. Another typical HA band that can be
observed is assigned to the stretching mode of OH
group at 3572 cm21 (þ). Moreover, it is also possible
to observe the loosening of OH groups (u) from
adsorbed, and bending mode of H2O after sintering
HA. Comparing the sintered HA [Fig. 3(b)] and HA
scaffolds [Fig. 3(c)] it is possible to confirm that no
differences were observed, and no characteristic
peaks of organic groups were found. This result
clearly indicates that the heat treatment cycle
applied is critical to avoid the undesired traces of
PU sponge. To further clarify this issue thermogravi-
metric analyses (TGA) were performed. Figure 4
shows the TGA of the PU sponges, PU sponges
impregnated with HA before burning and sintered
HA scaffolds. From results it can be seen that the ra-
tio between HA:PU sponge was 80:20 wt % [Fig.
4(b)]. Moreover, it can be seen that the melting point
of PU sponges is about 3008C, and PU sponge is
completely burned around 4008C. These findings
have demonstrated that the thermal treatment of the
HA/PU sponges at 9008C for the period of 24 h fol-
lowed by sintering at 13008C proved to be adequate
for the completely eliminating the PU sponges. This
is particularly evident in Figure 4(c), because no
mass changes on the sintered HA scaffolds were
detected.
It has been reported that sintering temperatures
and sintering time have great effect on sintered den-
sity of different apatites.30,31 Therefore, by increasing
the sintered density we expected to increase the final
Figure 3. FTIR spectra of (a) HA synthesized by a precip-
itation method, (b) HA sintered at 13008C, and (c) HA
scaffolds sintered at 13008C.
Figure 4. TGA analysis of (a) PU sponges, (b) PU sponge
impregnated with HA before burning, and (c) HA scaf-
folds sintered at 13008C.
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mechanical properties of the HA scaffolds. However,
it is also known that high temperatures may affect
the crystallinity and phase content of HA.32 Figure 5
shows the XRD pattern of HA before and after dif-
ferent heat treatments. Examining the XRD patterns
[Figs. 5(a–c)] and comparing with that of the stand-
ard file for HA from JCPDS (9–432) it can be
observed that the peaks are perfectly matching. The
XRD pattern of synthesized HA was found to be
amorphous [Fig. 5(a)]. After sintering the crystallin-
ity of HA increased and no decomposition products
such as a- or b-tricalcium phosphates (TCP)32 were
detected. The complementary FTIR data also
revealed the presence of typical OH groups [Fig.
3(b,c)] of the HA33 showing that the synthesized HA
is quite stable upon sintering of the materials at
13008C for 3 h. As previously reported, the XRD
data is also in good attainment with the FTIR spectra
[Fig. 3(a)]. FTIR spectrum show that carbonate ions
are observed in the as synthetized HA, the bands
assigned to carbonate m2 and m3 at 875 cm21 (#) and
at 1650–1300 cm21, respectively. The XRD study
revealed that the carbonate ions observed by FTIR
are assigned to surface ones, rather than being em-
bedded within the lattice of phosphate ions.29
To evaluate the microstructure of the HA scaf-
folds, SEM analysis were performed as shown in
Figure 6. The SEM images of the PU foams evi-
denced an ‘‘open-cell’’ and highly interconnected po-
rous structure [Fig. 6(a,b)], that facilitated the
impregnation of hydroxyapatite particulates. From
Figure 6(c) it can be observed that the architecture of
Figure 5. XRD patterns of (a) HA synthesized by a pre-
cipitation method, (b) HA sintered at 13008C, and (c) HA
scaffolds sintered at 13008C.
Figure 6. SEM micrographs of (a) PU sponge, (b) typical PU ‘‘open-cell’’ pore, (c) HA scaffold, and (d) typical macropore
of the HA scaffolds.
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the obtained HA scaffolds is analogous to the sacri-
fice template. In addition, the pore geometry is also
quite similar [Fig. 6(b,d)], showing a macroporous
and highly interconnected structure with pore size
comprised in the range of 50–600 lm. Such type of
morphology and pore dimension has been shown to
be adequate for bone tissue engineering pur-
poses.28,34,35 Note that the final pore architecture
could be easily controlled by changing the structure
of the PU foam. These results have demonstrated
that the centrifugation step is required to prevent
the formation of an external ‘‘skin-like’’ layer, that is
non-porous HA layer which can be a disadvantage
for the cells adhesion and in-growths during seeding
as well as proliferation and proper flow of culture
medium.35,36
The structure and architecture of the HA scaffolds
was further examined in a nondestructive manner
by means of l-CT analysis (Fig. 7). Figure 7(a) shows
the 2D morphometric analysis of the HA scaffolds. It
revealed that the mean porosity is about (67.8 6
5.0)%. Additionally, it can be seen that scaffolds
present a uniform architecture and pore distribution.
No gaps or empty spaces were observed, that is the
impregnation technique allows obtaining 3D struc-
tures mimicking the PU template. As previously
mentioned, besides the need of scaffolds high poros-
ity, the pores should be interconnected to allow the
diffusion of culture medium, metabolic wastes and
oxygen, and to facilitate the infiltration and prolifer-
ation of cells.37 The transversal [Fig. 7(b)] and longi-
tudinal [Fig. 7(c)] views of the HA scaffolds, clearly
showed that pore network is highly interconnected
(black arrows). This result demonstrates that the cen-
trifugation step not only prohibits the formation of
an external ‘‘skin-like’’ layer but also allows a uni-
form pore distribution and interconnectivity across
the HA scaffolds.
It is well known that a compromise between po-
rosity and mechanical properties exists, where
higher porosity results in lower mechanical strength
of the scaffold.38,39 The compressive strength of the
HA scaffolds was found to be 30.2 6 6.0 MPa. Previ-
ous reports have shown that for a HA scaffolds pos-
sessing 77% of porosity compressive strength was
about 17.4 MPa.40 Therefore, as compared with
others ceramic porous structures described in litera-
ture,23,40 our data present a good compromise
between porosity and mechanical performance, that
is (67.8 6 5.0)% and 30.2 6 6.0 MPa, respectively.
In the present work another issue that was
address consisted on evaluating in vitro, the bioactiv-
ity behavior of the HA scaffolds. Figure 8 shows the
SEM images of the surface of HA scaffolds before
and after immersion in SBF for 1–15 days. It was
possible to observe the deposition of precipitates
after 1 day [Fig. 8(b)], which tend to be more
pronounced for longer soaking time [Fig. 8(c,d)]. The
formation of these precipitates, which were covering
the whole HA surface, resembles the ‘‘cauliflower-
like’’ morphology of apatite formed in vitro onto bio-
active surfaces. Additionally, changes in calcium
(Ca) and phosphorus (P) ions in SBF solution was
Figure 7. l-CT analysis of HA scaffolds (a) 2D histomor-
phometric analysis, (b) transversal view, and (c) longitudi-
nal view (see complementary data). [Color figure can be
viewed in the online issue, which is available at www.
interscience.wiley.com.]
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also monitored by ICP. Figure 9 shows that Ca con-
centration increased in the SBF solution in the first
24 h. However, it is not detected an expected
increase in P concentration during this period. This
can be explained due to a fast consumption of P
during apatite nucleation phase. From day 1 to day
15, we assist to both decrease in the concentration of
Ca and P. This trend may be a consequence of the
consumption of both calcium and phosphorus upon
the deposition of the apatite layer at the surface of
the HA scaffolds, as detected by SEM [Fig. 8(b–d)]
images. These findings are in agreement with the
data available in literature,41 which has been shown
that HA are bioactive in nature due to a phenom-
enon involving the dissolution of calcium and phos-
phate ions from the HA.
As previously reported by Kirkpatrick et al., there
are several ways to assess the toxicity in vitro.42 In
this study, L929 cells were used for preliminarily
screen toxicity. Cytotoxicity of the HA scaffolds was
initially assessed through cell death observation in
the inverted microscope (Fig. 10). It can be observed
that after 72 h in contact with a latex rubber extract
(positive control), the L929 cells round up and
detached from the culture substratum, which is in-
dicative of the high cytotoxicity of the material [Fig.
10(b)]. On the contrary, when exposing to the differ-
ent concentrations of HA extract [Figs. 9 and 10(c–
f)], the L929 cells exhibited a normal morphology,
proliferated well and established a monolayer when
comparing with the negative control [Fig. 10(a)].
Therefore, these preliminary results show that no
Figure 8. SEM micrographs of the surface of the macroporous HA scaffolds after immersion in SBF for (a) 0 day, (b) 1
days, (c) 7 days, and (d) 15 days.
Figure 9. Profile of Ca and P ions in the SBF solution af-
ter soaking the macroporous HA scaffolds from day 0 up
to day 15.
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toxic traces of PU sponges remained on the HA scaf-
folds, and that HA scaffolds were biocompatible.
Complementarily, cell viability was investigated by
carrying out the MTS test (Fig. 11). The results once
corroborated the direct observation under the micro-
scope which showed that L929 cells were viable after
contacting with the different HA extract fluids for
the period of 72 h.
Cell viability and proliferation on the scaffolds is
one of the prerequisite for the 3D supports find
applications in the TE.43 To investigate other aspects
of cytotoxicity, such as the cell/scaffold interactions,
direct contact experiments were performed on the
macroporous HA scaffolds using rat bone marrow
stromal cells (RBMSCs). On the other hand, for opti-
mizing the cell seeding efficiency in respect to cell
adhesion and proliferative capacity of RBMSCs onto
Figure 10. L929 cells after contacting 72 h with the extract fluids (a) complete culture medium (negative control), (b) latex
rubber leachables (positive control), (c) 25% HA leachables, (d) 50% HA leachables, (e) 75% HA leachables, and (f) 100%
HA leachables. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
Figure 11. Percentage of L929 cell viability versus extract
fluids.
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the macroporous HA scaffolds different cell numbers
were tested. Figure 12 shows the luminescent cell vi-
ability assay of RBMSCs seeded onto the surface of
the HA scaffolds after culturing for 7 days. This
assay is based on a luminescence signal that is pro-
portional to the amount of ATP, which signals the
presence of metabolically active cells. From Figure
12 it can be observed that RBMSCs seeded at higher
cell numbers proliferated well and were viable after
culturing onto the macroporous HA scaffolds for 7
days. On the contrary, the low cell density has
shown to influence negatively the proliferation of
RBMSCs, as observed by the low cell numbers, after
7 days of culturing. Nevertheless, the number of via-
ble cells increased with an increase of culture time
for all cell densities tested. This data shows that cell
seeding efficiency increased with the increase in cell
concentration. This is an expected result because it
has been shown that cells needs a proper microen-
vironment not only with respect to 3D scaffold but
also by means of interacting with other cells through
cell–cell junctions and signaling.44,45 Therefore, this
data demonstrated that the cell seeding conditions,
namely the cell numbers needs to be optimized. The
high cell concentration tested seems to be more
adequate for the RBMSCs/HA constructs fully
achieve physiologic functions upon implantation.
Figure 13 shows the fluorescence microscopy
images of the HA scaffolds seeded with RBMSCs af-
ter performing a two-color fluorescence LIVE/DEAD
cell viability assay. This type of assay allows distin-
guishing live from dead cells because calcein-AM is
enzimatically converted into calcein, which is
retained within live cells and produces an intense
green fluorescence. On the other hand, dead cells are
stained in a bright red fluorescence because EtdD-1
only enters cells with damaged membranes and
binds to nucleic acids. From the fluorescence signals
it can be observed that RBMSCs adhered, prolifer-
ated and remained viable after 7 days. Moreover,
dead cells were present in low numbers as detected
by the low bright red fluorescence. Moreover, it can
be seen that RBMSCs were able to penetrate deeper
into the core of the HA scaffolds [Fig. 13(c)]. This is
an important data since it has been shown35,39 that
cell infiltration and distribution within the whole
scaffold will greatly affect the overall performance of
the cells/scaffold construct.
To further investigate the RBMSCs adhesion onto
the surface of the macroporous HA scaffolds SEM
analysis were also carried out. Figure 14 shows the
SEM images of the RBMSCs on the surface of the
macroporous HA scaffolds after 24 h and 7 days. It
can be observed that RBMSCs aggregated and
adhered onto the surface of the HA scaffolds but
presents a spherical morphology, after 24 h [Fig.
14(a)]. The morphology and small size are typical of
the cells initial anchorage stage. After a longer pe-
riod of culturing, RBMSCs spread actively and pre-
sented a flatten morphology showing a good anchor-
ing to the substrate by multiple lamellipodia [Fig.
14(b)].
Despite the biocompatibility and capacity of sup-
porting normal cellular functions, the macroporous
Figure 12. Cell viability assay of RBMSCs seeded at dif-
ferent cell densities onto the surface of the macroporous
HA scaffolds after 24 h, 3 and 7 days: (a) 5 3 102 cells per
scaffold (b) 1 3 103 cells per scaffold, (c) 5 3 103 cells per
scaffold, and (d) 1 3 104 cells per scaffold. Cell numbers
correlates with luminiscence.
Figure 13. Fluorescence microscopy images of the macroporous HA scaffolds seeded with RBMSCs at a cell density of
1 3 104 cells per scaffold after culturing for: (a) 24 h, (b) 3 days, and (c) 7 days. [Color figure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
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HA scaffolds also have to support the differentiation
of the stem cells both in vitro and in vivo. It can be
seen from Figure 14 that there are no indications of
osteogenic differentiation, namely the extracellular
mineralized matrix cannot be detected. This is an
expected result because osteogenic factors medium
were not added to culture medium. In contrast hy-
droxyapatite is known to lack the osteoinductive
capacity. This is a relevant feature that needs to be
met in a variety of bone related clinical strategies
and to which our research groups46,47 have been giv-
ing great deal of attention. Moreover, the present
data is promising because in future experiments we
propose to evaluate the HA/RBMSCs constructs
functionality, namely the ability of the HA scaffolds
to support the RBMSCs osteogenesis and bone for-
mation, in vitro and in vivo, respectively.
CONCLUSIONS
This work demonstrated that it is possible to pre-
pare sintered hydroxyapatite scaffolds with high
interconnectivity by impregnating an ‘‘open-cell’’ PU
sponge into a HA slurry, followed by burning the
‘‘sacrifice template’’. The preparation route was opti-
mized for producing macroporous HA structures
with controlled morphology, easily mediated by the
architecture of the PU sponge. In vitro tests have
demonstrated that such constructs are bioactive, as
observed by the formation of an apatite layer after 1
day of immersion in SBF solution. The biocompatible
behavior of the macroporous HA scaffold was dem-
onstrated as evidenced by the noncytotoxic effect
over L929 cells. Moreover, the cell/material interac-
tion tests have shown that the rat bone marrow stro-
mal cells adhered, proliferated well and remained
viable on the macroporous hydroxyapatite scaffolds.
More importantly, the cells were able to populate
the inner of the macroporous hydroxyapatite scaf-
folds. Therefore, the physicochemical and biological
properties of the macroporous hydroxyapatite scaf-
folds have shown to suitable for find applications in
bone tissue-engineering scaffolding.
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